Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.32B |
| 2 |
SCHR
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$1.22B |
| 3 |
Chevron
CVX
|
+$477M |
| 4 |
Pfizer
PFE
|
+$375M |
| 5 |
Amazon
AMZN
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$9.58B |
| 2 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.28B |
| 3 |
Schwab International Equity ETF
SCHF
|
+$4.53B |
| 4 |
Schwab U.S Small- Cap ETF
SCHA
|
+$4.13B |
| 5 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$2.63B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.59% |
| 2 | Financials | 12.1% |
| 3 | Healthcare | 10.58% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Invivyd
IVVD
$158M
| $215K | ﹤0.01% |
210,749
-289,312
| -58% | -$313K |
|
|
RDNW
3327
RideNow Group
RDNW
$238M
| $212K | ﹤0.01% |
44,218
+751
| +2% | +$3.1K |
|
3328
LiveOne
LVO
$61.7M
| $210K | ﹤0.01% |
22,108
+2,106
| +11% | +$31.7K |
|
3329
Southland Holdings
SLND
$30.2M
| $208K | ﹤0.01% |
56,232
-3,721
| -6% | -$14.5K |
|
|
MAPS
3330
DELISTED
WM TECHNOLOGY INC A
MAPS
| $207K | ﹤0.01% |
237,515
| – | – |
|
3331
Empire Petroleum
EP
$99.1M
| $206K | ﹤0.01% |
39,303
| – | – |
|
3332
Vanguard International Dividend Appreciation ETF
VIGI
$9.08B
| $206K | ﹤0.01% |
2,334
-629
| -21% | -$53.4K |
|
3333
Strawberry Fields REIT
STRW
$191M
| $205K | ﹤0.01% |
16,174
+2,774
| +21% | +$31.8K |
|
3334
Quantum-Si Incorporated
QSI
$155M
| $205K | ﹤0.01% |
232,360
-28,082
| -11% | -$27.3K |
|
3335
Fractyl Health
GUTS
$109M
| $204K | ﹤0.01% |
80,664
+29,262
| +57% | +$95.5K |
|
3336
Waldencast
WALD
$222M
| $203K | ﹤0.01% |
55,765
-7,437
| -12% | -$25.1K |
|
3337
Skye Bioscience
SKYE
$20M
| $202K | ﹤0.01% |
51,656
| – | – |
|
3338
Instil Bio
TIL
$48.3M
| $201K | ﹤0.01% |
+2,981
| New | +$70.2K |
|
3339
Aemetis
AMTX
$106M
| $196K | ﹤0.01% |
85,413
-13,963
| -14% | -$39.1K |
|
3340
NLI Holdings
NL
$281M
| $191K | ﹤0.01% |
25,715
| – | – |
|
3341
Ovid Therapeutics
OVID
$414M
| $191K | ﹤0.01% |
161,808
| – | – |
|
3342
CervoMed
CRVO
$23.9M
| $186K | ﹤0.01% |
12,722
| – | – |
|
3343
ThredUp
TDUP
$746M
| $184K | ﹤0.01% |
218,069
| – | – |
|
3344
INmune Bio
INMB
$46.5M
| $183K | ﹤0.01% |
33,990
-3,285
| -9% | -$23.4K |
|
|
CLPR
3345
Clipper Realty
CLPR
$45.2M
| $180K | ﹤0.01% |
31,569
+1,873
| +6% | +$8.38K |
|
3346
Galectin Therapeutics
GALT
$196M
| $179K | ﹤0.01% |
65,073
| – | – |
|
3347
VirTra
VTSI
$34.9M
| $177K | ﹤0.01% |
28,501
| – | – |
|
|
SWKH
3348
DELISTED
SWK Holdings
SWKH
| $176K | ﹤0.01% |
12,856
| – | – |
|
3349
McEwen Inc
MUX
$1.03B
| $174K | ﹤0.01% |
18,704
| – | – |
|
|
AKYA
3350
DELISTED
Akoya BioSciences
AKYA
| $171K | ﹤0.01% |
63,002
-112,886
| -64% | -$276K |
|
Similar funds
Charles Schwab's Q3 2024 Portfolio in Review
As of Q3 2024, Charles Schwab held 3,658 positions worth $524B, down 0.18% from $525B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab withdrew a net $33.1B in Q3 2024, closing 156 positions and reducing 1,005 holdings. Its most notable exit was Schwab US Large- Cap ETF, an estimated $9.58B position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Charles Schwab opened a new position in Shopify worth $194M.
- Charles Schwab's largest Q3 2024 buy was Shopify: 2,416,436 shares worth $194M.
- Charles Schwab added most to Apple in Q3 2024, an estimated $1.32B increase.
- Charles Schwab's biggest Q3 2024 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $958M.
- Charles Schwab fully exited Schwab US Large- Cap ETF in Q3 2024, selling an estimated $9.58B.
- Charles Schwab's ten largest holdings make up 21% of its $524B portfolio in Q3 2024.
- Charles Schwab opened 39 new positions and closed 156 in Q3 2024.
- Charles Schwab's portfolio value fell 0.18% quarter-over-quarter to $524B.
Based on Charles Schwab's 13F filing for Q3 2024, filed 12 Nov 2024.